BioSpace News Archive

Pharm Country

Cybrexa Therapeutics Selects Lead Clinical Candidate CBX-11, Combining its alphalex™ Technology with an Approved PARP Inhibitor to Treat Various Solid Tumors in Combination with Chemotherapy

CBX-11 selected based on robust efficacy and safety in combination with chemotherapy demonstrated in preclinical models Positive pre-IND Meeting with FDA supports on track plan to file IND in Q4 2019

January 3, 2019
·
2 min read
Business

E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer

E-Scape Bio has expanded its senior management team with the appointment of Carrolee Barlow, M.D., Ph.D., as chief medical officer, effective today.

January 3, 2019
·
2 min read
Business

Amunix Announces Appointment of Dr. Angie You as Chief Executive Officer and Dr. Rich Heyman as Chairman of the Board of Directors

Amunix Pharmaceuticals Inc. (“Amunix”), a biopharmaceutical company focused on the discovery and development of novel protein therapeutics, today announced the appointment of Angie You, Ph.D., as Chief Executive Officer, and Rich Heyman, Ph.D., as Chairman of the Board of Directors.

January 3, 2019
·
4 min read
Business

Cydan Announces Formation of Tiburio Therapeutics Inc. to Develop Treatments for Rare Neuroendocrine Tumors and Endocrine Diseases

Tiburio raises $31M in a Series A round to advance two clinical stage compounds TBR-760, for the treatment of nonfunctioning pituitary adenoma (NFPA), and TBR-065 for rare endocrine diseases

January 3, 2019
·
7 min read
BioCapital

Senseonics Announces First Study Participant Implanted in the U.S. as Part of the PROMISE 180-Day Sensor Clinical Study and the Submission of Key PMA Supplements to the FDA to Advance Current 90-Day Product

Senseonics Holdings, Inc. today announced that the extended life Eversense® XL sensor that lasts up to 180 days has been implanted in the first U.S. study participant as part of the clinical trial for pre-market application submission to the Food and Drug Administration.

January 3, 2019
·
4 min read
Pharm Country

BioNJ’s 26th Annual Dinner Meeting & Innovation Celebration to Honor New Jersey’s Innovators and the Patients and Advocates Who Inspire Them

Considered the kickoff event of the year for the life sciences industry, BioNJ’s 26th Annual Dinner Meeting & Innovation Celebration will take place Thursday, February 7, 2019 at the Hilton East Brunswick.

January 3, 2019
·
2 min read
Biotech Bay

Mindstrong Health Expands Series B Financing with $31M Investment led by General Catalyst

General Catalyst managing director Hemant Taneja and Jefferson Health CEO Dr. Stephen K. Klasko to join Board of Directors

January 3, 2019
·
1 min read
Deals

Medici Acquires Chiron Health Expanding Mission of Transforming Healthcare Delivery

Global Telehealth Platform Buys Secure Video Conferencing and Electronic Medical Record (EMR) Technology Firm

January 3, 2019
·
2 min read
Pharm Country

Charkit Chemical Garners NACD Responsible Distribution Verification For Its 6th Three-Year Cycle

Validates the Company’s Commitment to Health, Safety, Security, and Environmental Performance

January 3, 2019
·
2 min read
Business

Aquestive Therapeutics Appoints Gary H. Slatko, M.D. as Chief Medical Officer

Aquestive Therapeutics, Inc. today announced the appointment of Gary H. Slatko as SVP, Chief Medical Officer (CMO). Dr. Slatko will lead clinical and medical affairs for the company, and is reporting to CEO Keith J. Kendall, effective January 2, 2019.

January 3, 2019
·
2 min read